• Title/Summary/Keyword: 간염

Search Result 784, Processing Time 0.027 seconds

생활습관병 예방 프로젝트 3 예방하기 - 간염 제대로 관리하자

  • Lee, Jin-Han
    • 건강소식
    • /
    • v.37 no.12
    • /
    • pp.12-13
    • /
    • 2013
  • 일상 속에서 간염은 대수롭지 않게 취급되거나, 아예 사람들의 관심 밖에 있는 경우가 많다. 하지만 간염은 피로와 감기 몸살 증상을 일으키는 등 일상생활에 지장을 줄 뿐만 아니라 방치할 경우 간경화나 간암과 같은 치명적인 간 질환으로 발전해 당신의 생명을 위협할 수도 있다.

  • PDF

어린이건강관리 1-소아 건강검사는 영아기부터

  • Jo, Han-Ik
    • 건강소식
    • /
    • v.11 no.2 s.99
    • /
    • pp.16-18
    • /
    • 1987
  • 우리나라에서는 특히 간염의 발생율이 특히 높은 나라이며 신생아 시기에 걸린 간염은 성인이 된 후 간경화증으로 발전 된다고 하며, 나아가 간암으로 진행 될 가능성이 높으므로 출생 즉시 간염 백신을 접종하여 이후항체 형성 여부를 검사하여 면역기능이 생겼는지를 아는 것이 중요하다.

  • PDF

A Study on Health Belief of Convergency Relation of Preventive Behaviors and Seroprevalence Rate of Hepatitis A with Some Adults (예방행위와 항체 양성률과의 융합 관계를 통한 일부 성인의 A형 간염에 대한 건강신념 연구)

  • Ko, Seok-Gu;Lee, Ho-Shik
    • Journal of the Korea Convergence Society
    • /
    • v.7 no.1
    • /
    • pp.69-75
    • /
    • 2016
  • This study tries to look into the relationship between preventive behaviors and health belief for hepatitis A and seroprevanlence rate of hepatitis A. The cross ratio of seroprevanlence rate of hepatitis A significantly increased with an increase in age [1.210(95% CI, 1.158-1.264)], and those who had hepatitis A vaccination had a significantly higher cross ratio than those who didn't [19.591(95% CI 6.524-58.82)], and the more health motivation they had, the higher the cross ratio was [1.478(95% CI 1.053-2.075)]. To increase seroprevalence rate of hepatitis A, it is necessary to provide personal hygiene for health motivation and prevention education thoroughly and to give vaccination of hepatitis A.

Seroprevalence of antibody to the hepatitis C virus in methamphetamine abusers (Methamphetamin 남용입원환자들의 C형간염 항체 양성률에 관한 조사)

  • Kim, Jin-Kyoo;Lee, Ji-Ho;Cho, Byung-Mann;Lee, Soo-Il
    • Journal of Preventive Medicine and Public Health
    • /
    • v.24 no.4 s.36
    • /
    • pp.465-472
    • /
    • 1991
  • This study was designed to estimate the prevalence of hepatitis C virus(HCV) infection in drug abusers. The subjects were 141 inpatients who had been admitted to a general hospital with the symptoms and signs of methamphetamine intoxication. Seroprevalence of antibody to the hepatitis C virus(anti-HCV) was 60.3%(85/141) and it was higher in the group with increased frequency and duration of drug abuse, but such a relationship was not found in the seroprevalence of hepatitis B surface antigen(HBsAg). These findings suggested the possibility of high prevalence of HCV infection in methamphetamine abusers, and the importance of repetitive percutaneous injection in the transmission of HCV infection.

  • PDF

Convergence Studies on Knowledge, Attitude, and Health Belief Related to Hepatitis B Vaccination and Its Vaccination Rates of the College Students of Dental Hygienics and Dental Laboratory Technology Majors (치위생과와 치기공과 대학생들의 B형간염 예방접종에 대한 지식, 태도, 건강신념과 예방접종률 융합연구)

  • Kang, Hyun-Joo
    • Journal of the Korea Convergence Society
    • /
    • v.9 no.11
    • /
    • pp.107-115
    • /
    • 2018
  • The purpose of this study was to provide basic data for related researches on knowledge, attitude, and health belief related to hepatitis B and development of a preventive education program for the rise of its vaccination on college students of dental hygienics and dental laboratory technology majors. The questionnaires were distributed to a total of 252 students from April 26 to 30, 2018. The mean knowledge score of hepatitis B was 11.60 out of 20.0. The mean scores for their attitude and health belief on hepatitis B were 3.51 and 3.10 out of 4.0, respectively. Only 38.9% of the subjects were vaccinated and 53.6% of them were not educated. The factors affecting the vaccination were clinical training experience and prevention education. It is essential to provide healthcare education on knowledge, attitude, and health belief related to hepatitis B and to develop a convergent education program because the students may be manpower for healthcare institutions in the future.

Clinical Features of Non-A, B, C Viral Hepatitis in Children (소아에서 발생한 비-A, B, C형 바이러스성 간염의 임상 고찰)

  • Son, Seung Kook;Park, Jae Hong
    • Pediatric Gastroenterology, Hepatology & Nutrition
    • /
    • v.8 no.1
    • /
    • pp.41-48
    • /
    • 2005
  • Purpose: Non-A, B, C viral hepatitis is the name given to the disease with clinical viral hepatitis, but in which serologic evidence of A, B, C hepatitis has not been found. Little is known about the etiology and clinical features of non-A, B, C viral hepatitis in children. Methods: A clinical analysis of 45 cases with non-A, B, C viral hepatitis who were admitted to the Department of Pediatrics, Pusan National University Hospital, from January 2001 to June 2004 was carried out retrospectively. Patients who were positive for HBsAg, anti-HAV and anti-HCV and had toxic, metabolic, autoimmune, or neonatal hepatitis were excluded in this study. Results: Among 45 cases of non-A, B, C viral hepatitis, the etiology was unknown in 26 (57.8%), CMV (cytomegalovirus) in 14 (31.1%), EBV (Epstein Barr virus) in 2 (4.4%), HSV (herpes simplex virus) in 2 (4.4%) and RV (rubella virus) in 1 (2.2%). Twenty seven out of 45 (60.0%) patients were under 1 year of age. Sixteen (33.3%) patients had no specific clinical symptoms and were diagnosed incidentally. On physical examination, twenty seven out of 45 patients (60.0%) had no abnormal findings. Forty three out of 45 patients (95.6%) showed classic clinical course of acute viral hepatitis, whereas fulminant hepatitis developed in two patients. Mean serum ALT (alanine aminotransferase) level was $448.7{\pm}771.9IU/L$. Serum ALT level was normalized in 31 out of 45 patients (81.6%) within 6 months and all patients within 18 months. Aplastic anemia was complicated in a case. Conclusion: Although most patients with non-A, B, C viral hepatitis showed a good prognosis, a careful follow-up would be necessary because some of them had a clinical course of chronic hepatitis, fulminant hepatitis and severe complication such as aplastic anemia.

  • PDF

특이성 떨어지는 진단시약의 문제점 해결

  • Korea Invention Promotion Association
    • 발명특허
    • /
    • v.31 no.4 s.358
    • /
    • pp.54-56
    • /
    • 2006
  • 현재 병원 및 의원에서는 GOT, GPT 등의 간 질환 진단시약을 사용하고 있다. 하지만 이것들은 특이성이 떨어진다는 문제점을 가지고 있다. 또한 초기 염증 및 급성간염 진단에 있어서는 유용할 지 모르나 만성간염, 간경변, 간암에 있어서는 수치가 정상으로 나타나는 경우도 있어 오진 및 의료분쟁의 원인이 되기도 하 는 등의 치명적인 오류를 안고 있다. 이렇듯 간의 초기 염증 및 급성간염 진단만 가능하던 현재의 간질환 진단시약이 가지고 있는 문제점을 해결하여 만성간염, 간경변, 간암 등까지도 확실하게 구별할 수 있음은 물론 간질환의 진행상태까지도 판단할 수 있는 세계 유일의 제품을 개발하게 되었다. 이는 간경변, 간암의 경우 9 6 %의 높은 판정비율을 나타낸다.

  • PDF

Prevalence of the Nonalcoholic Fatty Liver Disease in Obese Children (소아 비만증에서 비알코올성 지방간염의 유병률)

  • Hwang, Sung Woog;Kim, Duk Hee;Kim, Ho Seong
    • Clinical and Experimental Pediatrics
    • /
    • v.48 no.1
    • /
    • pp.13-20
    • /
    • 2005
  • Purpose : Obesity is, along with metabolic syndrome, closely related with nonalcoholic fatty liver disease. This study tried to evaluate the prevalence of nonalcoholic liver disease in obese children and verify the factors associated with the disease. Methods : Two hundred and seventy nine children who showed a body mass index of 95 percentile over the baseline in health examinations of surrounding schools were evaluated. Questionnaires, body measurements, blood examinations, and ultrasonographic measurements of abdominal fat were examined. Results : Out of 279 children enrolled for the study, 27 children were found to possess nonalcoholic liver disease(9.7%). Among those found to be positive for nonalcoholic liver disease, it's prevalence increased to 15.2%(22 out of 144 children) among children with severe obesity. Factors known to be involved with metabolic syndrome, namely waist/hip circumference ratio and thickness of abdominal fat, were found to be closely related to nonalcoholic fatty liver as well. Conclusion : The prevalence of nonalcoholic fatty liver in obese children was 9.7%, with higher incidence observable in severer obesity. Factors responsible for metabolic syndrome were closely associated with nonalcoholic fatty liver disease, and the level of insulin resistance, which is an useful index in both diseases, can be utilized in evaluation of the effect of treatment and control of risk factors.